Department of Internal Medicine I, José-Carreras-Centre, Saarland University Medical School, Homburg (Saar), Germany.
Department of Endocrinology and Metabolism, Academic Medical Centre, Amsterdam, The Netherlands.
Br J Haematol. 2019 Feb;184(3):384-391. doi: 10.1111/bjh.15659. Epub 2018 Nov 18.
Patients with Gaucher disease (GD) have an increased risk of monoclonal gammopathies for which antigenic targets might play a role in their pathogenesis. Here we report the identification of saposin C (sapC) as high-titre (1:1 000 000) target structure of 7/16 GD-associated paraproteins. Anti-sapC immunoglobulin (Ig) showed identity with the paraprotein Ig type and subclass in each patient that showed anti-sapC immunoreactivity. Absorption and depletion studies completely removed the paraprotein from the sera of GD patients. No immunoreactivity against sapC was detected in healthy donors and in other plasma cell dyscrasias, demonstrating that anti-sapC reactivity is highly restricted to GD. Several uncharacterized forms of post-translational modified sapC were detected but their role in the pathogenesis is not clear. We confirm the frequent presence of low-titre (1:250) anti-lysolipid reactivities in the sera of GD patients but we could show that this immunoreactivity is not mediated by the paraprotein and is not restricted to GD patients.
戈谢病(Gaucher disease,GD)患者发生单克隆丙种球蛋白病的风险增加,其抗原靶标可能在发病机制中发挥作用。本研究报告了发现神经鞘磷脂激活蛋白 C(saposin C,sapC)是 16 例 GD 相关副蛋白的高滴度(1:1 000 000)靶结构。抗 sapC 免疫球蛋白(immunoglobulin,Ig)与每个表现出抗 sapC 免疫反应性的患者的副蛋白 Ig 类型和亚型相同。吸收和耗竭研究完全从 GD 患者的血清中去除了副蛋白。在健康供体和其他浆细胞异常中未检测到针对 sapC 的免疫反应性,表明抗 sapC 反应性高度局限于 GD。检测到几种未表征的翻译后修饰形式的 sapC,但它们在发病机制中的作用尚不清楚。我们证实 GD 患者血清中经常存在低滴度(1:250)的抗脂类物质反应性,但我们能够表明这种免疫反应性不是由副蛋白介导的,并且不限于 GD 患者。